$156 Million is the total value of Asymmetry Capital Management, L.P.'s 34 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 106.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | Buy | ASCENDIS PHARMA A/S - ADRadr | $12,568,000 | +78.5% | 81,442 | +71.1% | 8.08% | +49.8% |
| PODD | New | INSULET CORP | $9,735,000 | – | 41,147 | +100.0% | 6.26% | – |
| QDEL | New | QUIDEL CORP | $8,625,000 | – | 39,314 | +100.0% | 5.54% | – |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $8,559,000 | -20.9% | 155,232 | -9.4% | 5.50% | -33.6% |
| GH | Sell | GUARDANT HEALTH INC | $7,698,000 | -1.2% | 68,863 | -28.3% | 4.95% | -17.1% |
| CYTK | Buy | CYTOKINETICS INC | $7,366,000 | +51.7% | 340,253 | +65.1% | 4.74% | +27.3% |
| FLDM | New | FLUIDIGM CORP | $7,268,000 | – | 978,158 | +100.0% | 4.67% | – |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $7,208,000 | +11.8% | 161,253 | -26.6% | 4.63% | -6.2% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $6,979,000 | -35.9% | 93,308 | -46.0% | 4.49% | -46.2% |
| ILMN | New | ILLUMINA INC | $6,321,000 | – | 20,451 | +100.0% | 4.06% | – |
| SAGE | Sell | SAGE THERAPEUTICS INC | $6,262,000 | -23.7% | 102,462 | -48.1% | 4.02% | -35.9% |
| KURA | New | KURA ONCOLOGY INC | $6,143,000 | – | 200,484 | +100.0% | 3.95% | – |
| UNH | Buy | UNITEDHEALTH GROUP INC | $5,819,000 | +52.9% | 18,666 | +44.7% | 3.74% | +28.3% |
| BNR | New | BURNING ROCK BIOTECH LTD-ADRadr | $5,451,000 | – | 217,362 | +100.0% | 3.50% | – |
| TXG | Sell | 10X GENOMICS INC-CLASS A | $5,425,000 | +19.5% | 43,512 | -14.4% | 3.49% | +0.3% |
| FATE | Buy | FATE THERAPEUTICS INC | $4,531,000 | +21.0% | 113,366 | +3.8% | 2.91% | +1.5% |
| HZNP | New | HORIZON THERAPEUTICS PLC | $4,039,000 | – | 51,995 | +100.0% | 2.60% | – |
| FBRX | New | FORTE BIOSCIENCES INC | $3,872,000 | – | 79,823 | +100.0% | 2.49% | – |
| BMYRT | Sell | BRISTOL-MYERS SQUIBB-CVRrts | $3,511,000 | -72.4% | 1,560,327 | -56.1% | 2.26% | -76.9% |
| ATRS | Sell | ANTARES PHARMA INC | $3,225,000 | -9.7% | 1,194,530 | -8.1% | 2.07% | -24.3% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $3,195,000 | +118.8% | 36,571 | +61.8% | 2.05% | +83.6% |
| NCNA | Buy | NUCANA PLC-ADRadr | $2,658,000 | +187.4% | 514,122 | +200.7% | 1.71% | +141.0% |
| AVDL | Sell | AVADEL PHARMACEUTICALS PLCadr | $2,625,000 | -39.1% | 520,830 | -2.4% | 1.69% | -48.9% |
| PACB | New | PACIFIC BIOSCIENCES OF CALIF | $2,537,000 | – | 257,044 | +100.0% | 1.63% | – |
| MEIP | New | MEI PHARMA INC | $2,457,000 | – | 787,359 | +100.0% | 1.58% | – |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $2,212,000 | +75.0% | 129,042 | +152.7% | 1.42% | +46.9% |
| FSDC | New | FS DEVELOPMENT CORP-A | $2,169,000 | – | 193,728 | +100.0% | 1.39% | – |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $1,632,000 | – | 11,447 | +100.0% | 1.05% | – |
| ITOS | New | ITEOS THERAPEUTICS INC | $1,425,000 | – | 57,751 | +100.0% | 0.92% | – |
| GRAY | New | GRAYBUG VISION INC | $1,171,000 | – | 92,159 | +100.0% | 0.75% | – |
| NVUS | New | NOVUS THERAPEUTICS INC | $1,034,000 | – | 1,088,907 | +100.0% | 0.66% | – |
| PMVP | New | PMV PHARMACEUTICALS INC | $884,000 | – | 24,892 | +100.0% | 0.57% | – |
| EQ | New | EQUILLIUM INC | $828,000 | – | 143,543 | +100.0% | 0.53% | – |
| SELB | New | SELECTA BIOSCIENCES INC | $137,000 | – | 55,343 | +100.0% | 0.09% | – |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -34,652 | -100.0% | -0.77% | – |
| NXTC | Exit | NEXTCURE INC | $0 | – | -48,456 | -100.0% | -0.80% | – |
| UBX | Exit | UNITY BIOTECHNOLOGY INC | $0 | – | -120,179 | -100.0% | -0.80% | – |
| GRTS | Exit | GRITSTONE ONCOLOGY INC | $0 | – | -222,817 | -100.0% | -1.13% | – |
| MRNS | Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -586,243 | -100.0% | -1.14% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -25,000 | -100.0% | -1.17% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -211,063 | -100.0% | -1.21% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -100,544 | -100.0% | -1.29% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -900,733 | -100.0% | -1.44% | – |
| TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -53,344 | -100.0% | -1.85% | – |
| BNTX | Exit | BIONTECH SEadr | $0 | – | -38,626 | -100.0% | -1.98% | – |
| BIO | Exit | BIO-RAD LABORATORIES-A | $0 | – | -6,434 | -100.0% | -2.23% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -234,753 | -100.0% | -2.71% | – |
| PTCT | Exit | PTC THERAPEUTICS | $0 | – | -73,708 | -100.0% | -2.86% | – |
| CNC | Exit | CENTENE CORP | $0 | – | -77,402 | -100.0% | -3.77% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -159,197 | -100.0% | -4.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CENTENE CORP | 21 | Q4 2021 | 10.7% |
| UNITEDHEALTH GROUP INC | 21 | Q4 2021 | 7.2% |
| AMICUS THERAPEUTICS INC | 20 | Q4 2021 | 8.0% |
| PTC THERAPEUTICS INC | 19 | Q3 2021 | 13.8% |
| AERIE PHARMACEUTICALS INC | 16 | Q4 2019 | 9.9% |
| JAZZ PHARMACEUTICALS PLC | 15 | Q2 2021 | 10.2% |
| BIO-RAD LABRATORIES | 13 | Q2 2021 | 6.3% |
| NEVRO CORP | 12 | Q3 2018 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 12 | Q4 2018 | 6.5% |
| NUCANA PLC-ADR | 12 | Q4 2020 | 2.6% |
View Asymmetry Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-01-19 |
| 13F-HR | 2021-11-04 |
| 13F-HR | 2021-07-28 |
| 13F-HR | 2021-05-11 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-06 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-12 |
| 13F-HR | 2019-11-12 |
View Asymmetry Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.